Novavax, Inc.
NVAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $70,445 | $239,240 | $666,655 | $88,311 |
| % Growth | -70.6% | -64.1% | 654.9% | – |
| Cost of Goods Sold | $21,496 | $14,225 | $14,115 | $36,669 |
| Gross Profit | $48,949 | $225,015 | $652,540 | $51,642 |
| % Margin | 69.5% | 94.1% | 97.9% | 58.5% |
| R&D Expenses | $98,274 | $77,633 | $88,937 | $104,380 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $31,655 | $40,612 | $48,090 | $78,342 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $97,038 | $1,100 | $0 | $0 |
| Operating Expenses | $226,967 | $119,345 | $137,027 | $182,722 |
| Operating Income | -$178,018 | $105,670 | $515,513 | -$131,080 |
| % Margin | -252.7% | 44.2% | 77.3% | -148.4% |
| Other Income/Exp. Net | -$25,018 | $1,784 | $4,333 | $57,499 |
| Pre-Tax Income | -$203,036 | $107,454 | $519,846 | -$73,581 |
| Tax Expense | -$657 | $946 | $1,200 | $7,449 |
| Net Income | -$202,379 | $106,508 | $518,646 | -$81,030 |
| % Margin | -287.3% | 44.5% | 77.8% | -91.8% |
| EPS | -1.25 | 0.66 | 3.22 | -0.51 |
| % Growth | -289.4% | -79.5% | 731.4% | – |
| EPS Diluted | -1.25 | 0.6 | 2.93 | -0.51 |
| Weighted Avg Shares Out | 162,353 | 162,019 | 161,049 | 160,241 |
| Weighted Avg Shares Out Dil | 162,353 | 177,215 | 177,625 | 160,241 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5,482 | $5,518 | $5,723 | $7,585 |
| Depreciation & Amortization | $6,585 | $7,563 | $8,340 | $12,517 |
| EBITDA | -$190,969 | $120,535 | $533,909 | -$53,479 |
| % Margin | -271.1% | 50.4% | 80.1% | -60.6% |